Zoetis Inc (ZTS) Plans Quarterly Dividend of $0.13

Zoetis Inc (NYSE:ZTS) declared a quarterly dividend on Wednesday, February 14th, Wall Street Journal reports. Investors of record on Friday, April 20th will be paid a dividend of 0.126 per share on Friday, June 1st. This represents a $0.50 dividend on an annualized basis and a yield of 0.68%. The ex-dividend date of this dividend is Thursday, April 19th.

Zoetis has increased its dividend by an average of 13.4% per year over the last three years and has increased its dividend annually for the last 4 consecutive years. Zoetis has a payout ratio of 21.1% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Zoetis to earn $2.94 per share next year, which means the company should continue to be able to cover its $0.50 annual dividend with an expected future payout ratio of 17.0%.

Shares of Zoetis (ZTS) traded up $1.22 during mid-day trading on Wednesday, reaching $74.46. 2,906,757 shares of the company were exchanged, compared to its average volume of 2,961,047. Zoetis has a fifty-two week low of $52.00 and a fifty-two week high of $80.13. The company has a market capitalization of $36,080.00, a price-to-earnings ratio of 39.19, a P/E/G ratio of 1.61 and a beta of 1.07. The company has a debt-to-equity ratio of 2.45, a current ratio of 2.80 and a quick ratio of 1.95.

Several brokerages have issued reports on ZTS. BMO Capital Markets set a $78.00 price target on shares of Zoetis and gave the company a “hold” rating in a report on Monday, January 22nd. Zacks Investment Research lowered shares of Zoetis from a “hold” rating to a “sell” rating and set a $83.00 price target on the stock. in a report on Saturday, January 13th. Craig Hallum reissued a “buy” rating and issued a $85.00 price target (up previously from $77.00) on shares of Zoetis in a report on Tuesday, January 2nd. Cantor Fitzgerald set a $85.00 price target on shares of Zoetis and gave the company a “buy” rating in a report on Tuesday, January 2nd. Finally, BidaskClub lowered shares of Zoetis from a “hold” rating to a “sell” rating in a report on Wednesday, November 1st. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and fourteen have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $73.72.

TRADEMARK VIOLATION NOTICE: This story was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://www.americanbankingnews.com/2018/02/14/zoetis-inc-zts-plans-quarterly-dividend-of-0-13.html.

Zoetis Company Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Dividend History for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply